Systematic review / meta-analysis / 2013
High serum urate levels were linked to a lower risk of Parkinson's disease, especially in men.
A meta-analysis of six studies with 33,185 participants evaluated the link between serum urate and Parkinson's disease (PD). High serum urate was associated with a 33% reduction in PD incidence overall (RR=0.67; 95% CI, 0.50-0.91), showing statistically significant protective effects in men (RR=0.60; 95% CI, 0.40-0.90) but not in women. A dose-response trend was observed (RR=0.77; 95% CI, 0.68-0.88), and high levels seemed to slow clinical decline in PD patients (RR=0.56; 95% CI, 0.43-0.72).
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis
- Who was studied
- 6 studies involving 33,185 participants
- What was measured
- Parkinson's disease incidence and clinical decline
THE PAPER
Serum urate and the risk of Parkinson's disease: results from a meta-analysis.
Shen C, Guo Y, Luo W, Lin C, Ding M. Can J Neurol Sci, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.